Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06180577 · ClinicalTrials.gov registry record
A Survey Study to Assess the Accessibility of the Nerivio Device At School
A clinical trial, sponsored by Theranica.
- Completed
- Registry status
- 332
- Enrollment target
NCT06180577 is a clinical trial that has completed, run by Theranica. The registered enrollment target is 332 participants.
The verdict
NCT06180577 has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- 332 participants
- Enrollment target
Study Summary
This is a retrospective survey-study to assess the accessibility, preference, and frequency of adolescents using Nerivio by itself, in combination with pharmacological medications, or not at all, in the school setting. The study population is prescribed Nerivio users, under the age of 18 years old, who have used the Nerivio device at least once. The study will be conducted electronically, and will include eligibility questions, an electronic informed consent form signed by the parent/legal guardian (e-ICF), an assent form signed by the adolescent patient (e-Assent), and an e-survey relating to the management of headaches due to migraine attacks. Participants will be recruited from Nerivio's userbase and will be compensated for their participation.
Interventions
- DEVICE Nerivio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2024-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06180577
The ClinicalTrials.gov registry entry for NCT06180577 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranica, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nerivio is the first listed.
NCT06180577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06180577 about?
NCT06180577 is a clinical study titled "A Survey Study to Assess the Accessibility of the Nerivio Device At School". This is a retrospective survey-study to assess the accessibility, preference, and frequency of adolescents using Nerivio by itself, in combination with pharmacological medications, or not at all, in the school setting. The study population is prescribed Nerivio users, under the age of 18 years old, ...
What is the current status of trial NCT06180577?
This trial is currently completed. The enrollment target is 332 participants. The study started on 2024-02-01. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT06180577?
The interventions under investigation include: Nerivio (DEVICE).
Who is sponsoring clinical trial NCT06180577?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.